Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2015 Jan 20.

Published in final edited form as: Int J Radiat Oncol Biol Phys. 2011 Feb 1;79(2):549–558. doi: 10.1016/j.ijrobp.2010.08.013

Table 1.

Percentage of mice with PSA < 25 ng/ml and tumor volume < 100 mm³.

Group	LNCaP (6 weeks)			PC3 (4 weeks)
	PSA<25 ng/ml	TV <100 mm³	Combined	TV <100mm³
Ad-Luc	31% (5/16)	25% (4/16)	25% (4/16)	30% (3/10)
Ad-E2F1	53% (9/17)	53% (9/17)^‡	53% (9/17)^‡	70% (7/10)^‡
Ad-Luc+RT	22% (6/27)	33% (9/27)	18% (5/27)	24% (6/25)
Ad-E2F1+RT	85% (23/27)^*	93% (25/27)^*	85% (23/27)^*	68% (17/25)^†
Ad-Luc (pooled)¹	26% (11/43)	30% (13/33)	21% (9/43)	26% (9/35)
Ad-E2F1 (pooled)¹	73% (32/44)^†	77% (34/44)^†	73% (32/44)^†	69% (24/35)^†

¹

Pooled data for the corresponding control (Ad-Luc) and test vector (Ad-E2F1)

^*

p<0.05 compared to all groups above

^†

p<0.05 compared to the group above

^‡

p<0.1 compared to the group above